Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label on the study history page updated from v3.6.2 to v3.6.3, signaling a new build of the page. The change does not alter any study details, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-07-04T13:37:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a small platform update and does not alter study information or navigation.
    Difference
    0.1%
    Check dated 2026-06-27T06:26:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added 'No longer looking for participants', indicating enrollment has paused or ended. The history also shows Revision: v3.6.0 and removes Revision: v3.5.5 from the log.
    Difference
    0.4%
    Check dated 2026-06-13T05:13:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.5, updating the metadata to reflect the latest history entry. It replaces the previous revision stamp.
    Difference
    0.1%
    Check dated 2026-06-05T22:43:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the Study Record History and Revision: v3.5.3 was removed. This reflects an update to the page's revision metadata in the history section.
    Difference
    0.1%
    Check dated 2026-05-15T15:34:10.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The record history page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site/version change rather than a modification to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:24.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.